Company Description

PapiVax Biotech (PBI) is a biotechnology company that intends to become a global leader in immunotherapy for chronic viral infections and related cancers through application of our state-of-the-art immunology and virology expertise, first to develop safe and effective treatments for human papillomavirus (HPV) infections and related cancers and then to expand application of our immunotherapy platforms against other chronic virus infection-related human cancers.